0001654954-20-007958.txt : 20200723
0001654954-20-007958.hdr.sgml : 20200723
20200723170037
ACCESSION NUMBER: 0001654954-20-007958
CONFORMED SUBMISSION TYPE: D/A
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20200723
DATE AS OF CHANGE: 20200723
EFFECTIVENESS DATE: 20200723
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: GT Biopharma, Inc.
CENTRAL INDEX KEY: 0000109657
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 941620407
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D/A
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-368883
FILM NUMBER: 201044187
BUSINESS ADDRESS:
STREET 1: 310 N. WESTLAKE BLVD.
STREET 2: SUITE 206
CITY: WESTLAKE VILLAGE
STATE: CA
ZIP: 91362
BUSINESS PHONE: (800) 304-9888
MAIL ADDRESS:
STREET 1: 310 N. WESTLAKE BLVD.
STREET 2: SUITE 206
CITY: WESTLAKE VILLAGE
STATE: CA
ZIP: 91362
FORMER COMPANY:
FORMER CONFORMED NAME: OXIS INTERNATIONAL INC
DATE OF NAME CHANGE: 19940916
FORMER COMPANY:
FORMER CONFORMED NAME: DDI PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19920703
FORMER COMPANY:
FORMER CONFORMED NAME: DIAGNOSTIC DATA INC /DE/
DATE OF NAME CHANGE: 19850312
D/A
1
primary_doc.xml
X0708
D/A
LIVE
0000109657
GT Biopharma, Inc.
9350 Wilshire Blvd., Suite 203
Beverly Hills
CA
CALIFORNIA
90212
800-304-9888
DELAWARE
OXIS INTERNATIONAL INC
DDI PHARMACEUTICALS INC
DIAGNOSTIC DATA INC /DE/
Corporation
true
Anthony
Cataldo
9350 Wilshire Blvd., Suite 203
Beverly Hills
CA
CALIFORNIA
90212
Director
Executive Officer
Steven
Weldon
9350 Wilshire Blvd., Suite 203
Beverly Hills
CA
CALIFORNIA
90212
Director
Biotechnology
Decline to Disclose
- 06b
true
0001654954-20-006561
2020-04-20
false
true
true
Debt convertible into equity.
false
0
Indefinite
5607000
Indefinite
false
18
0
0
250000
true
A portion of the proceeds of this offering will be used for general corporate purposes, including compensation to executive officers in their roles as employees.
GT Biopharma, Inc.
/s/ Steven Weldon
Steven Weldon
Chief Financial Officer
2020-07-23